10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Financial Results, Press Release
CFO Departure - Andy Sassine Steps Down from Arcturus Therapeutics
Announces Third Quarter 2025 Financial Update and Pipeline Progress
Investor Presentation
Reg. FD
Receives Approval in Japan for Two-Dose Vial of KOSTAIVE®, a Self-Amplifying mRNA COVID-19 Vaccine
Announces Second Quarter 2025 Financial Update and Pipeline Progress
FY 2025
Notice of Late Filing for Quarterly Report
Q3
Q2
Q1
FY 2024
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Delisting Amendment